Loading startup

DealFlow OS
Market indexPublic companiesMorning briefingTerminal
Request accessSign in

DealFlow

Terminal access

IndexTop moversSignals

Public markets

Public companiesMorning briefing
Browse index
1

10x Science

SeedFunding signal
10xscience.comB2BSan Francisco, CA, USA
Market index

Market data is refreshed once per day from public sources. Information may be incomplete or outdated — verify independently before making decisions. This is not investment advice.

Investor read

Evidence-bound summary — expand sections for movement, risks, and signals.

Memo snapshot · Jun 28, 2026, 6:31 PM

Worth a meetingEvidence-bound analyst verdict
  • •Funding: Raised $4.8M across 1 funding round. Latest: $4.8M Seed (Apr 2026). Investors: Initialized Capital, Y Combinator, Civilization Ventures, Founder Factor.
  • •Named backers in indexed sources: Initialized Capital, Y Combinator, Civilization Ventures, Founder Factor.
  • •Hiring: 2 hiring‑related row(s); role‑spam risk if mostly generic boards
  • •Product/news: 5 product/news‑styled row(s); headline risk without filings

DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.

TL;DR

Seed (YC)

10x Science AI-native protein characterization for drug development.

Funding

Raised $4.8M across 1 funding round. Latest: $4.8M Seed (Apr 2026). Investors: Initialized Capital, Y Combinator, Civilization Ventures, Founder Factor. (Medium).

Quick read

  • •10x Science AI-native protein characterization for drug development.
  • •Reported angle: 10x Science | Y Combinator

Key signals

Funding

Raised $4.8M across 1 funding round. Latest: $4.8M Seed (Apr 2026). Investors: Initialized Capital, Y Combinator, Civilization Ventures, Founder Factor. (Medium).

Hiring

2 hiring‑related row(s); role‑spam risk if mostly generic boards (High).

Product / news

5 product/news‑styled row(s); headline risk without filings (High).

Evidence summary

Verified facts

  • •10x Science AI-native protein characterization for drug development.
  • •Reported angle: 10x Science | Y Combinator

Recent movers

  • •May 20, 2026 · ycombinator.com — 10x Science | Y Combinator
  • •May 11, 2026 · Blog / news — 10x Science: AI-Native Software for Scientists
  • •May 11, 2026 · Careers — 10x Science: AI-Native Software for Scientists

+1 more in Recent movement below

  • •May 20, 2026 · ycombinator.com — 10x Science | Y Combinator
  • •May 11, 2026 · Blog / news — 10x Science: AI-Native Software for Scientists
  • •May 11, 2026 · Careers — 10x Science: AI-Native Software for Scientists
  • •May 20, 2026 · prnewswire.com — 10x Science Raises $4.8M Seed
  • •Initialized Capital
  • •Y Combinator
  • •Civilization Ventures
  • •Founder Factor

Suggested next steps

  • ▸Open a founder conversation this month; validate traction claims against the indexed evidence.
  • ▸Add to the active watchlist so new signals trigger alerts.

Funding & hiring signals

fundingConfidence: low

AI is spitting out more potential drugs than ever. This startup wants to figure out which ones matter.

AI is spitting out more potential drugs than ever. This startup wants to figure out which ones matter. https://techcrunch.com/2026/04/22/ai-is-spitting-out-more-potential-drugs-than-ever-this-start-up-wants-to-figure-out-which-ones-matter/

Affected score: noObserved: Jun 29, 2026

Weak funding evidence: mention does not include a parsed raise amount/round and may refer to non-funding context.

funding_articleMay 20, 2026Confidence: high

10x Science Raises $4.8M Seed

Oversubscribed seed led by Initialized Capital; AI-native protein characterization platform; YC W26 company.

Affected score: yesObserved: May 20, 2026Round: SeedAmount: $4.8M
raisedseed

Open roles (indexed)

No open roles indexed yet.

Public index
89Activity 85/100Strong public activity signal
7D+7 (+8.5%)
30D+34 (+61.8%)
High Confidence

The index price and activity score are algorithmic estimates based on observed public company-level signals. They may be incomplete, stale, or inaccurate and are not investment, legal, tax, or business advice.

Source health

  • public_page:customersok
    Last checked Thu, Jul 2, 04:21 PM
  • public_page:pricingok
    Last checked Thu, Jul 2, 04:21 PM
  • public_page:pressok
    Last checked Thu, Jul 2, 04:21 PM
  • public_page:newsok
    Last checked Thu, Jul 2, 04:21 PM
  • public_page:blogok
    Last checked Thu, Jul 2, 04:21 PM
  • public_page:jobsok
    Last checked Thu, Jul 2, 04:21 PM
  • public_page:careersok
    Last checked Thu, Jul 2, 04:21 PM
  • public_page:aboutok
    Last checked Thu, Jul 2, 04:21 PM
  • public_page:homeok
    Last checked Thu, Jul 2, 04:21 PM
  • fundingok
    Last checked Mon, Jun 29, 05:43 PM

    discovery:google:google_cse_quota_exhausted

  • public_page:newsroomok
    Last checked Mon, Jun 29, 05:43 PM
  • public_page:productok
    Last checked Mon, Jun 29, 05:43 PM
  • public_page:investorsok
    Last checked Mon, Jun 29, 05:43 PM
  • public_page:changelogok
    Last checked Mon, Jun 29, 05:43 PM
  • public_page:teamok
    Last checked Mon, Jun 29, 05:43 PM
  • public_page:productsok
    Last checked Mon, Jun 29, 05:43 PM
  • public_page:_pressok
    Last checked Mon, May 11, 04:47 AM
  • public_page:_newsok
    Last checked Mon, May 11, 04:47 AM
  • public_page:_jobsok
    Last checked Mon, May 11, 04:47 AM
  • public_page:_companyok
    Last checked Mon, May 11, 04:47 AM
  • public_page:_careersok
    Last checked Mon, May 11, 04:47 AM
  • public_page:_blogok
    Last checked Mon, May 11, 04:47 AM
  • public_page:_aboutok
    Last checked Mon, May 11, 04:47 AM
  • public_page:_ok
    Last checked Mon, May 11, 04:47 AM

Signal timeline

17 dated public signals · newest on the right

Funding
Hiring
Product
Code
Press
Company
Other
Apr 19, 2026May 28, 2026Jul 5, 2026
Funding (2)Hiring (2)Product (2)Code (2)Press (4)Company (3)Other (2)

Signal breakdown

Latest momentum signal per category. Expand a card to inspect raw payloads.

Public source summary

Total evidence rows
17
Latest evidence
Thu, Jul 2, 04:20 PM

Source types found

about_pageblogcareers_pagefundingfunding_articlegithubhiringnewsofficial_siteotherpressproduct

Strongest / recent news-style rows

  • 10x Science: AI-Native Software for Scientists

    Customers · Thu, Jul 2, 04:20 PM · confidence 70%high quality

  • 10x Science: AI-Native Software for Scientists

    Pricing · Thu, Jul 2, 04:20 PM · confidence 70%high quality

  • 10x Science: AI-Native Software for Scientists

    Press · Thu, Jul 2, 04:20 PM · confidence 70%high quality

Public signal timeline

Newest first · 17 event(s)

1
Thu, Jul 2, 04:20 PM · product · 70% · publichigh quality10x Science: AI-Native Software for Scientists

Source: Customers

Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.

Source ↗
2
Thu, Jul 2, 04:20 PM · product · 70% · publichigh quality10x Science: AI-Native Software for Scientists

Source: Pricing

Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.

Source ↗
3
Thu, Jul 2, 04:20 PM · news · 70% · publichigh quality10x Science: AI-Native Software for Scientists

Source: Press

Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.

Source ↗
4
Thu, Jul 2, 04:20 PM · news · 70% · publichigh quality10x Science: AI-Native Software for Scientists

Source: News

Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.

Source ↗
5
Thu, Jul 2, 04:20 PM · blog · 70% · publichigh quality10x Science: AI-Native Software for Scientists

Source: Blog

Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.

Source ↗
6
Thu, Jul 2, 04:20 PM · hiring · 70% · publichigh quality10x Science: AI-Native Software for Scientists

Source: Jobs page

Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.

Source ↗
7
Thu, Jul 2, 04:20 PM · careers_page · 70% · publichigh quality10x Science: AI-Native Software for Scientists

Source: Careers page

Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.

Source ↗
8
Thu, Jul 2, 04:20 PM · about_page · 70% · publichigh quality10x Science: AI-Native Software for Scientists

Source: About page

Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.

Source ↗
9
Thu, Jul 2, 04:20 PM · official_site · 70% · publichigh quality10x Science: AI-Native Software for Scientists

Source: Homepage

Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.

Source ↗
10
Mon, Jun 29, 08:53 AM · github · 92% · verified_publichigh qualityGitHub org: 10x-Science

Source: github_api

Source ↗
11
Mon, Jun 29, 08:53 AM · github · 92% · verified_publichigh qualityGitHub repo: markmiro/10x-science

Source: github_api

Source ↗
12
Wed, May 20, 06:16 PM · press · 85% · verified_publichigh quality10x Science | Y Combinator

Founders from Carolyn Bertozzi's Stanford lab; W26 batch.

Source ↗
13
Mon, May 11, 04:47 AM · about_page · 70% · publichigh quality10x Science: AI-Native Software for Scientists

Source: About / company

Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.

Source ↗
14
Mon, Jun 29, 05:43 PM · funding · 78% · publicmedium qualityAI is spitting out more potential drugs than ever. This startup wants to figure out which ones matter.

Source: techcrunch

AI is spitting out more potential drugs than ever. This startup wants to figure out which ones matter. https://techcrunch.com/2026/04/22/ai-is-spitting-out-more-potential-drugs-than-ever-this-start-up-wants-to-figure-out-which-ones-matter/

Source ↗
15
Mon, Jun 29, 05:43 PM · other · 50% · publicmedium quality1901 in science

Source: wikipedia

Source ↗
16
Mon, Jun 29, 05:43 PM · other · 50% · publicmedium quality1900 in science

Source: wikipedia

Source ↗
17
Wed, May 20, 06:16 PM · funding_article · 88% · verified_publicmedium quality10x Science Raises $4.8M Seed

Oversubscribed seed led by Initialized Capital; AI-native protein characterization platform; YC W26 company.

Source ↗

Official / company site

1 row(s)

The company's own site — the authoritative description of what they sell and to whom. Marketing-controlled, so treat claims as positioning rather than verified traction.

official_site·Thu, Jul 2, 04:20 PM·Confidence 70%high qualitypublic
10x Science: AI-Native Software for Scientists

Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.

Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.

Open source ↗

News

9 row(s)

Third-party press coverage. Independent reporting corroborates company claims; repeated coverage across outlets is a momentum signal.

product·Thu, Jul 2, 04:20 PM·Confidence 70%high qualitypublic
10x Science: AI-Native Software for Scientists

Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.

Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.

Open source ↗
product·Thu, Jul 2, 04:20 PM·Confidence 70%high qualitypublic
10x Science: AI-Native Software for Scientists

Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.

Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.

Open source ↗
news·Thu, Jul 2, 04:20 PM·Confidence 70%high qualitypublic
10x Science: AI-Native Software for Scientists

Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.

Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.

Open source ↗
news·Thu, Jul 2, 04:20 PM·Confidence 70%high qualitypublic
10x Science: AI-Native Software for Scientists

Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.

Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.

Open source ↗
about_page·Thu, Jul 2, 04:20 PM·Confidence 70%high qualitypublic
10x Science: AI-Native Software for Scientists

Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.

Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.

Open source ↗
press·Wed, May 20, 06:16 PM·Confidence 85%high qualityverified_public
10x Science | Y Combinator

Founders from Carolyn Bertozzi's Stanford lab; W26 batch.

Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.

Open source ↗
about_page·Mon, May 11, 04:47 AM·Confidence 70%high qualitypublic
10x Science: AI-Native Software for Scientists

Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.

Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.

Open source ↗
other·Mon, Jun 29, 05:43 PM·Confidence 50%medium qualitypublic
1901 in science

Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.

Open source ↗
other·Mon, Jun 29, 05:43 PM·Confidence 50%medium qualitypublic
1900 in science

Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.

Open source ↗

Funding / news

2 row(s)

Funding announcements and investor-database records. The strongest public signal of capitalization: round, amount, and syndicate quality when disclosed.

funding·Mon, Jun 29, 05:43 PM·Confidence 78%medium qualitypublic
AI is spitting out more potential drugs than ever. This startup wants to figure out which ones matter.

AI is spitting out more potential drugs than ever. This startup wants to figure out which ones matter. https://techcrunch.com/2026/04/22/ai-is-spitting-out-more-potential-drugs-than-ever-this-start-up-wants-to-figure-out-which-ones-matter/

Why it matters: Funding signal — seed round per this source; verify against the linked original before relying on it.

Open source ↗
funding_article·Wed, May 20, 06:16 PM·Confidence 88%medium qualityverified_public
10x Science Raises $4.8M Seed

Oversubscribed seed led by Initialized Capital; AI-native protein characterization platform; YC W26 company.

Why it matters: Funding signal — Seed per this source; verify against the linked original before relying on it.

Open source ↗

Hiring

2 row(s)

Open roles and careers pages. Active hiring implies runway to spend and shows where the company is investing (engineering vs GTM vs ops).

hiring·Thu, Jul 2, 04:20 PM·Confidence 70%high qualitypublic
10x Science: AI-Native Software for Scientists

Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.

Why it matters: Hiring signal — open roles imply runway to spend and show where the company is investing.

Open source ↗
careers_page·Thu, Jul 2, 04:20 PM·Confidence 70%high qualitypublic
10x Science: AI-Native Software for Scientists

Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.

Why it matters: Hiring signal — open roles imply runway to spend and show where the company is investing.

Open source ↗

GitHub

2 row(s)

Public engineering activity. Sustained commits, releases, and stars indicate real product development and, for dev tools, developer adoption.

github·Mon, Jun 29, 08:53 AM·Confidence 92%high qualityverified_public
GitHub org: 10x-Science

Why it matters: Engineering signal — public repo activity evidences active development and possible developer adoption.

Open source ↗
github·Mon, Jun 29, 08:53 AM·Confidence 92%high qualityverified_public
GitHub repo: markmiro/10x-science

Why it matters: Engineering signal — public repo activity (2 stars, JavaScript) evidences active development.

Open source ↗

Blog

1 row(s)

Company blog and newsletters. Shipping cadence and technical depth of posts hint at product velocity and team quality.

blog·Thu, Jul 2, 04:20 PM·Confidence 70%high qualitypublic
10x Science: AI-Native Software for Scientists

Peptide mapping, upgraded for protein therapeutics. 10x faster processing. Find what current tools miss. No file conversions, no friction.

Why it matters: Company publishing — post cadence and depth hint at product velocity.

Open source ↗

Private workspace

Sign in as an active team member to view private notes, watchlist controls, transcript evidence, and interaction history.

Sign in
DealFlow OS · Public market terminal
Privacy PolicyTerms & Conditions